EFA Technologies
Infectious Disease Diagnostic System
Startup Seed Health Tech & Life Sciences Est. 2016
Total Raised
$9.49M
Seed
Last Round
$6.5M
9 rounds
Investors
7
5 public
Team
4
11-50 employees
Confidence
99/100
News
4
articles
Patents
1
About
EFA Technologies is developing the RevDx, an affordable handheld blood test diagnostic tool. The RevDx is a mobile end-point solution for performing automatic microscopy tests, including whole blood sampling and an automatic diagnosis of blood count. The product is easy to operate and uses a blood sample from finger prick without the need for laboratory conditions or specific preparations, enabling users to make real-time informed decisions. The RevDx is a disease-mapping solution for integrated community case management. The real-time, multichannel platform is a programmable portable lab that aims to automatically diagnose infectious diseases, starting with parasitology and blood cell count, in order to enable safe, precise, and affordable testing, treating, and tracking.
Classification
Sector
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesDigital HealthcareDigital Medical Diagnostics
Core Technology
SensingPlatforms & InterfacesSoftwareArtificial IntelligenceMachine Learning
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2BB2B2CB2G
Tags
digital-healthcareblood-testmhealthtelemedicineinfectious-diseasediagnosticsmedical-devicessensorsclinicsimage-processingdeep-learningsoftware-applicationsdata-analyticsmachine-learningartificial-intelligencedoctorshome-care
Funding & Events
Sep 2020
Seed $2.1M
Undisclosed Investor(s), Undisclosed Investor(s), Maccabi Health Fund, Arc Impact, Merchavia Holdings, eHealth Ventures
May 2020
Non-equity $240K
Israel Innovation Authority
Mar 2024
Non-equity Undisclosed
Mar 2021
Non-equity $1.2M
Israel Innovation Authority
Jan 2022
Convertible Debt $3.65M
Merchavia Holdings
Jan 2022
SAFE $1M
eHealth Ventures (Lead)
Jan 2016
Non-equity Undisclosed
Israel Innovation Authority
Dec 2018
Seed $1.3M
eHealth Ventures, Undisclosed Investor(s), Merchavia Holdings
Apr 2024
Debt Financing $6.5M
Maccabi Healthcare Services, Israel Innovation Authority , Arc Impact, Merchavia Holdings, eHealth Ventures
News (4)
Apr 9, 2024 · www.globenewswire.com
growth-positive
EFA Technologies, pioneer in portable blood labs, enters Brazilian market after Anvisa approval of its portable RevDx device
CustomersInvestmentExpand
Mar 20, 2019 · www.prnewswire.com
growth-positive
Merchavia Expands Its Investments in Diagnostics: The Company to Invest NIS 1 Million in EFA - Engineering for All Ltd.
Investment
Dec 11, 2018 · en.globes.co.il
growth-positive
Digital diagnostic lab co EfA raises $900,000
Investment
Dec 11, 2018 · www.prnewswire.com
growth-positive
eHealth Ventures Invests in "Engineering for All" - Disruptive Lab-on-a-Chip Diagnostic Device
Investment
Details
Product Stage
Clinical Trial
Employees
11-50
Exact Count
17
District
North District
Founded
2016
Registrar
515337301
Crunchbase
efa-technologies
Locations
HaYozma Street 6, Yokne'am Illit, Israel
4901 Hampden Lane, Bethesda, MD, USA
Links
Website
LinkedIn
Admin
Last Update
Sep 21, 2024
Verified by
Natalia Golczar
Claimed
Yes
Missing
markets
Team (4)
Yoel Ezra
Founder & CEO
Founder
Eli Mor
Co-Founder - no longer with the company
Amir Lubashevsky
CMO
Oran Zohar
Head of Software R&D